Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats
About this item
Full title
Author / Creator
Publisher
Berlin: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Berlin: Springer
Subjects
More information
Scope and Contents
Contents
Delta9-tetrahydrocannabinol (Delta9-THC), the main psychoactive ingredient of marijuana, as well as synthetic cannabinoid (CB1) receptor agonists, has led to negative or equivocal results when tested with the intravenous self-administration procedure, the best validated behavioural model for evaluating abuse liability of drugs in experimental anima...
Alternative Titles
Full title
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_17899484
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_17899484
Other Identifiers
ISSN
0033-3158
E-ISSN
1432-2072
DOI
10.1007/s002130100734
